Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: The use of public gene-targeted ES cell resources

Brain Research

Volumn 1091, Issue 1, 2006, Pages 235-242

  Parker, Lisan L ^a   Gao, Jiangang ^a   Zuo, Jian ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Auditory brainstem response; Deafness; ES cell; Gene trap; Myosin; Real time PCR

Indexed keywords

MESSENGER RNA; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE MUTATION; GENE TARGETING; GENOMICS; GERMLINE MICRONUCLEUS; HEARING LOSS; HOMOZYGOSITY; LEUKOCYTE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; ANIMALS; AUDITORY THRESHOLD; CELL LINE; COCHLEA; DISEASE MODELS, ANIMAL; EMBRYO; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GENE TARGETING; HEARING LOSS; HUMANS; MICE; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS;

EID: 33745594285     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.032     Document Type: Article

References (36)

1. Arrondel C., Vodovar N., Knebelmann B., Grunfeld J.P., Gubler M.C., Antignac C., and Heidet L. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol. 13 (2002) 65-74
2. Balduini C.L., Iolascon A., and Savoia A. Inherited thrombocytopenias: from genes to therapy. Haematologica 87 (2002) 860-880
3. Conti M.A., Even-Ram S., Liu C., Yamada K.M., and Adelstein R.S. Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice. J. Biol. Chem. 279 (2004) 41263-41266
4. D'Apolito M., Guarnieri V., Boncristiano M., Zelante L., and Savoia A. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes. Gene 286 (2002) 215-222
5. Deutsch S., Rideau A., Bochaton-Piallat M.L., Merla G., Geinoz A., Gabbiani G., Schwede T., Matthes T., Antonarakis S.E., and Beris P. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 102 (2003) 529-534
6. Di Pumpo M., Noris P., Pecci A., Savoia A., Seri M., Ceresa I.F., and Balduini C.L. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. Haematologica 87 (2002) 943-947
7. Dong F., Li S., Pujol-Moix N., Luban L.C., Shin S.W., Seo J.H., Ruiz-Saez A., Demeter J., Langdon S., and Kelley M.J. Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br. J. Haematol. 130 (2005) 620-627
8. Gao J., Cheon K., Nusinowitz S., Liu Q., Bei D., Atkins K., Azimi A., Daiger S.P., Farber D.B., Heckenlively J.R., Pierce E.A., Sullivan L.S., and Zuo J. Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5698-5703
9. Gao J., Wu X., and Zuo J. Targeting hearing genes in mice. Brain Res. Mol. Brain Res. 132 (2004) 192-207
10. Ghiggeri G.M., Caridi G., Magrini U., Sessa A., Savoia A., Seri M., Pecci A., Romagnoli R., Gangarossa S., Noris P., Sartore S., Necchi V., Ravazzolo R., and Balduini C.L. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am. J. Kidney Dis. 41 (2003) 95-104
11. Golomb E., Ma X., Jana S.S., Preston Y.A., Kawamoto S., Shoham N.G., Goldin E., Conti M.A., Sellers J.R., and Adelstein R.S. Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. J. Biol. Chem. 279 (2004) 2800-2808
12. Heath K.E., Campos-Barros A., Toren A., Rozenfeld-Granot G., Carlsson L.E., Savige J., Denison J.C., Gregory M.C., White J.G., Barker D.F., Greinacher A., Epstein C.J., Glucksman M.J., and Martignetti J.A. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am. J. Hum. Genet. 69 (2001) 1033-1045
13. Hu A., Wang F., and Sellers J.R. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function. J. Biol. Chem. 277 (2002) 46512-46517
14. Kelley M.J., Jawien W., Ortel T.L., and Korczak J.F. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat. Genet. 26 (2000) 106-108
15. Kunishima S. May-Hegglin anomaly-From genome research to clinical laboratory. Rinsho Byori 51 (2003) 898-904
16. Kunishima S., Matsushita T., Kojima T., Amemiya N., Choi Y.M., Hosaka N., Inoue M., Jung Y., Mamiya S., Matsumoto K., Miyajima Y., Zhang G., Ruan C., Saito K., Song K.S., Yoon H.J., Kamiya T., and Saito H. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J. Hum. Genet. 46 (2001) 722-729
17. Kunishima S., Matsushita T., Kojima T., Sako M., Kimura F., Jo E.K., Inoue C., Kamiya T., and Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab. Invest. 83 (2003) 115-122
18. Lalwani A.K., Linthicum F.H., Wilcox E.R., Moore J.K., Walters F.C., San Agustin T.B., Mislinski J., Miller M.R., Sinninger Y., Attaie A., and Luxford W.M. A five-generation family with late-onset progressive hereditary hearing impairment due to cochleosaccular degeneration. Audiol. Neuro-otol. 2 (1997) 139-154
19. Lalwani A.K., Luxford W.M., Mhatre A.N., Attaie A., Wilcox E.R., and Castelein C.M. A new locus for nonsyndromic hereditary hearing impairment, DFNA17, maps to chromosome 22 and represents a gene for cochleosaccular degeneration. Am. J. Hum. Genet. 64 (1999) 318-323
20. Lalwani A.K., Goldstein J.A., Kelley M.J., Luxford W., Castelein C.M., and Mhatre A.N. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am. J. Hum. Genet. 67 (2000) 1121-1128
21. Leal A., Endele S., Stengel C., Huehne K., Loetterle J., Barrantes R., Winterpacht A., and Rautenstrauss B. A novel myosin heavy chain gene in human chromosome 19q13.3. Gene 312 (2003) 165-171
22. Liberman M.C., Gao J., He D.Z., Wu X., Jia S., and Zuo J. Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature 419 (2002) 300-304
23. Liu X.Z., Ouyang X.M., Xia X.J., Zheng J., Pandya A., Li F., Du L.L., Welch K.O., Petit C., Smith R.J., Webb B.T., Yan D., Arnos K.S., Corey D., Dallos P., Nance W.E., and Chen Z.Y. Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss. Hum. Mol. Genet. 12 (2003) 1155-1162
24. Marigo V., Nigro A., Pecci A., Montanaro D., Di Stazio M., Balduini C.L., and Savoia A. Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. Genomics 83 (2004) 1125-1133
25. Matsushita T., Hayashi H., Kunishima S., Hayashi M., Ikejiri M., Takeshita K., Yuzawa Y., Adachi T., Hirashima K., Sone M., Yamamoto K., Takagi A., Katsumi A., Kawai K., Nezu T., Takahashi M., Nakashima T., Naoe T., Kojima T., and Saito H. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Biochem. Biophys. Res. Commun. 325 (2004) 1163-1171
26. Mhatre A.N., Kim Y., Brodie H.A., and Lalwani A.K. Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9. Otol. Neurotol. 24 (2003) 205-209
27. Mhatre A.N., Li J., Kim Y., Coling D.E., and Lalwani A.K. Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear. J. Neurosci. Res. 76 (2004) 296-305
28. Pecci A., Noris P., Invernizzi R., Savoia A., Seri M., Ghiggeri G.M., Sartore S., Gangarossa S., Bizzaro N., and Balduini C.L. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. Br. J. Haematol. 117 (2002) 164-167
29. Pujol-Moix N., Kelley M.J., Hernandez A., Muniz-Diaz E., and Espanol I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders. Haematologica 89 (2004) 330-337
30. Sellers J.R. Myosins: a diverse superfamily. Biochim. Biophys. Acta 1496 (2000) 3-22
31. Seri M., Cusano R., Gangarossa S., Caridi G., Bordo D., Lo Nigro C., Ghiggeri G.M., Ravazzolo R., Savino M., Del Vecchio M., d'Apolito M., Iolascon A., Zelante L.L., Savoia A., Balduini C.L., Noris P., Magrini U., Belletti S., Heath K.E., Babcock M., Glucksman M.J., Aliprandis E., Bizzaro N., Desnick R.J., and Martignetti J.A. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat. Genet. 26 (2000) 103-105
32. Seri M., Pecci A., Di Bari F., Cusano R., Savino M., Panza E., Nigro A., Noris P., Gangarossa S., Rocca B., Gresele P., Bizzaro N., Malatesta P., Koivisto P.A., Longo I., Musso R., Pecoraro C., Iolascon A., Magrini U., Rodriguez Soriano J., Renieri A., Ghiggeri G.M., Ravazzolo R., Balduini C.L., and Savoia A. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, 2003. Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82 (2003) 203-215
33. Simons M., Wang M., McBride O.W., Kawamoto S., Yamakawa K., Gdula D., Adelstein R.S., and Weir L. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ. Res. 69 (1991) 530-539
34. Stryke D., Kawamoto M., Huang C.C., Johns S.J., King L.A., Harper C.A., Meng E.C., Lee R.E., Yee A., L'Italien L., Chuang P.T., Young S.G., Skarnes W.C., Babbitt P.C., and Ferrin T.E. BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res. 31 (2003) 278-281
35. Sullivan L.S., Heckenlively J.R., Bowne S.J., Zuo J., Hide W.A., Gal A., Denton M., Inglehearn C.F., Blanton S.H., and Daiger S.P. Mutations in a novel retina-specific gene cause autosomal dominant retinitis pigmentosa. Nat. Genet. 22 (1999) 255-259
36. Zambrowicz B.P., Abuin A., Ramirez-Solis R., Richter L.J., Piggott J., BeltrandelRio H., Buxton E.C., Edwards J., Finch R.A., Friddle C.J., Gupta A., Hansen G., Hu Y., Huang W., Jaing C., Key Jr. B.W., Kipp P., Kohlhauff B., Ma Z.Q., Markesich D., Payne R., Potter D.G., Qian N., Shaw J., Schrick J., Shi Z.Z., Sparks M.J., Van Sligtenhorst I., Vogel P., Walke W., Xu N., Zhu Q., Person C., and Sands A.T. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14109-14114